BL Pharmtech Corp.

KOSDAQ:A065170 Voorraadrapport

Marktkapitalisatie: ₩36.0b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

BL Pharmtech Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Hyo-Lim Lee

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

BL Pharmtech (KOSDAQ:065170) Has Debt But No Earnings; Should You Worry?

Sep 03
BL Pharmtech (KOSDAQ:065170) Has Debt But No Earnings; Should You Worry?

Some Confidence Is Lacking In BL Pharmtech Corp.'s (KOSDAQ:065170) P/S

May 21
Some Confidence Is Lacking In BL Pharmtech Corp.'s (KOSDAQ:065170) P/S

Is BL Pharmtech (KOSDAQ:065170) A Risky Investment?

Mar 07
Is BL Pharmtech (KOSDAQ:065170) A Risky Investment?

Reflecting on Next Bt's (KOSDAQ:065170) Share Price Returns Over The Last Three Years

Mar 14
Reflecting on Next Bt's (KOSDAQ:065170) Share Price Returns Over The Last Three Years

Does Next Bt (KOSDAQ:065170) Have A Healthy Balance Sheet?

Jan 20
Does Next Bt (KOSDAQ:065170) Have A Healthy Balance Sheet?

Next Bt's (KOSDAQ:065170) Shareholders Are Down 43% On Their Shares

Nov 28
Next Bt's (KOSDAQ:065170) Shareholders Are Down 43% On Their Shares

CEO

Hyo-Lim Lee

no data

Tenure

Mr. Hyo-Lim Lee serves as the Chief Executive Officer of BL Pharmtech Corp. (formerly known as NRD Co., Ltd.).